These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6937941)

  • 1. Long-term therapy with carbenoxolone in the prevention of recurrence of gastric ulcer. Natural history and evolution of important side-effects and measures to avoid them.
    Ganguli PC; Mohamed SD
    Scand J Gastroenterol Suppl; 1980; 65():63-71. PubMed ID: 6937941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carbenoxolone: ulcer-healing and metabolic effects.
    Wright PA; Reed PI; Davies WA; St John DJ; Young GP; House FR; Gribble RJ; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():41-8. PubMed ID: 6937940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbenoxolone patients with gastric ulcers. A double-blind trial.
    Schwamberger K; Reissigl H
    Scand J Gastroenterol Suppl; 1980; 65():59-62. PubMed ID: 7010529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pirenzepine and carbenoxolone in the treatment of chronic gastric ulcer. A double-blind endoscopic trial.
    Bianchi Porro G; Petrillo M; Lazzaroni M; Mazzacca G; Sabbatini F; Piai G; Dobrilla G; De Pretis G; Daniotti S
    Hepatogastroenterology; 1985 Dec; 32(6):293-5. PubMed ID: 3912314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of carbenoxolone in long term treatment of recurrent duodenal ulcer (author's transl)].
    Berndt H; Gütz HJ
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(2):98-102. PubMed ID: 6786855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance of carbenoxolone sodium in elderly patients (author's transl)].
    Hagenmüller F; Wurbs D; Classen M
    Leber Magen Darm; 1977 Dec; 7(6):385-8. PubMed ID: 593029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of carbenoxolone sodium in the treatment of duodenal ulcer.
    Nagy GS
    Gastroenterology; 1978 Jan; 74(1):7-10. PubMed ID: 336453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the combinations atropine + cyproheptadine and atropine + carbenoxolone in duodenal ulcer therapy.
    Tárnok F; Deák G; Jávor T; Mózsik G; Nagy L; Patty I
    Int J Tissue React; 1983; 5(3):315-21. PubMed ID: 6654627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial.
    Cook PJ; Vincent-Brown A; Lewis SI; Perks S; Jewell DP; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():93-101. PubMed ID: 7010531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer.
    La Brooy SJ; Taylor RH; Hunt RH; Golding PL; Laidlaw JM; Chapman RG; Pounder RE; Vincent SH; Colin-Jones DG; Milton-Thompson GJ; Misiewicz JJ
    Br Med J; 1979 May; 1(6174):1308-9. PubMed ID: 376054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Undesirable effects of carbenoxolone treatment in patients with ulcus ventriculi].
    Henrichsen L; Pedersen H; Jensen KB; Wulff HR
    Ugeskr Laeger; 1976 Dec; 138(51):3265-7. PubMed ID: 793123
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer.
    Schenk J; Schmack B; Rösch W; Domschke W
    Scand J Gastroenterol Suppl; 1980; 65():103-7. PubMed ID: 7010527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirenzepine and carbenozolone in gastric ulcer. Preliminary results of a multicentre double-blind controlled clinical trial.
    Barbara L; Belsasso E; Blasi A; Caenazzo E; Di Febo G; Di Mario F; Giorgi-Conciato M; Marletta F; Miglioli M; Petrillo M; Salvagnini M; Scalabrin G
    Scand J Gastroenterol Suppl; 1979; 57():21-4. PubMed ID: 396653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Duogastrome (carbenoxolone sodium) for the treatment of duodenal ulcer: a multicentre study.
    Archambault A; Farley A; Gosselin D; Martin F; Birkett JP
    Can Med Assoc J; 1977 Nov; 117(10):1155-9. PubMed ID: 603844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.